Trinity Biotech

TRIB

Market cap $6.14M

TRIB Hedge Fund Activity: Q1 2026 in Review

23 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2026, worth a combined $589K — down 13% from $673K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TRIB and 5 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $166K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $14.8K sold.

• 23 institutional investors held Trinity Biotech (TRIB) as of Q1 2026, down from 27 in Q4 2025.
• Funds reported $589K of Trinity Biotech stock for Q1 2026, down 13% quarter-over-quarter.
• 5 funds opened new Trinity Biotech positions in Q1 2026 and 8 closed out, a net change of -3 holders.
• The largest Trinity Biotech buyer in Q1 2026 was Yorkville Advisors Global, an estimated $166K added.
• The largest Trinity Biotech seller in Q1 2026 was Two Sigma Investments, an estimated $14.8K sold.

Based on aggregated 13F filings for Q1 2026.